mad-id.org参考文章(210)
Thomas V Riley, Claudia Thomas, Restriction of third generation cephalosporin use reduces the incidence of Clostridium difficile-associated diarrhoea in hospitalised patients. Communicable diseases intelligence quarterly report. ,vol. 27, ,(2003)
C. C. Blyth, N. M. Gilroy, S. D. Guy, S. T. Chambers, E. Y. Cheong, T. Gottlieb, S. L. McGuinness, K. A. Thursky, Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014 Internal Medicine Journal. ,vol. 44, pp. 1333- 1349 ,(2014) , 10.1111/IMJ.12598
Julia L. Reffert, Winter J. Smith, Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. ,vol. 34, pp. 845- 857 ,(2014) , 10.1002/PHAR.1434
Anthony M Nicasio, Joseph L Kuti, David P Nicolau, The Current State of Multidrug-Resistant Gram-Negative Bacilli in North America Pharmacotherapy. ,vol. 28, pp. 235- 249 ,(2008) , 10.1592/PHCO.28.2.235
Clare C. Walsh, Michelle P. McIntosh, Anton Y. Peleg, Carl M. Kirkpatrick, Phillip J. Bergen, In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa Journal of Antimicrobial Chemotherapy. ,vol. 70, pp. 3042- 3050 ,(2015) , 10.1093/JAC/DKV221
O.A. Cornely, M. Cuenca-Estrella, J.F. Meis, A.J. Ullmann, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases Clinical Microbiology and Infection. ,vol. 20, pp. 1- 4 ,(2014) , 10.1111/1469-0691.12569
Shmuel Shoham, Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Therapeutics and Clinical Risk Management. ,vol. 4, pp. 637- 640 ,(2008) , 10.2147/TCRM.S2838
WEI LONG, XINGQI DENG, YU ZHANG, GANG LU, JUAN XIE, JIANGUO TANG, Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia Respirology. ,vol. 16, pp. 819- 824 ,(2011) , 10.1111/J.1440-1843.2011.01978.X
Sylvia B Debast, Martijn P Bauer, Ed J Kuijper, Committee, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection Clinical Microbiology and Infection. ,vol. 20, pp. 1- 26 ,(2014) , 10.1111/1469-0691.12418
Dimitri Drekonja, Jon Reich, Selome Gezahegn, Nancy Greer, Aasma Shaukat, Roderick MacDonald, Indy Rutks, Timothy J. Wilt, Fecal Microbiota Transplantation forClostridium difficileInfection Annals of Internal Medicine. ,vol. 162, pp. 630- 638 ,(2015) , 10.7326/M14-2693